BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8132329)

  • 1. Role of human major histocompatibility complex DQ molecules in superantigenicity of streptococcus-derived protein.
    Esaki Y; Fukui Y; Sudo T; Yamamoto K; Inamitsu T; Nishimura Y; Hirokawa K; Kimura A; Sasazuki T
    Infect Immun; 1994 Apr; 62(4):1228-35. PubMed ID: 8132329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional interaction between human histocompatibility leukocyte antigen (HLA) class II and mouse CD4 molecule in antigen recognition by T cells in HLA-DR and DQ transgenic mice.
    Yamamoto K; Fukui Y; Esaki Y; Inamitsu T; Sudo T; Yamane K; Kamikawaji N; Kimura A; Sasazuki T
    J Exp Med; 1994 Jul; 180(1):165-71. PubMed ID: 8006580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superantigenicity of helper T-cell mitogen (SPM-2) isolated from culture supernatants of Streptococcus pyogenes.
    Rikiishi H; Okamoto S; Sugawara S; Tamura K; Liu ZX; Kumagai K
    Immunology; 1997 Jul; 91(3):406-13. PubMed ID: 9301530
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell repertoire in a strain of transgenic C57BL/6 mice with the HLA-DRA gene on the X-chromosome.
    Fukui Y; Esaki Y; Kimura A; Hirokawa K; Nishimura Y; Sasazuki T
    Immunogenetics; 1993; 37(3):204-11. PubMed ID: 8420827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA class II polymorphisms determine responses to bacterial superantigens.
    Llewelyn M; Sriskandan S; Peakman M; Ambrozak DR; Douek DC; Kwok WW; Cohen J; Altmann DM
    J Immunol; 2004 Feb; 172(3):1719-26. PubMed ID: 14734754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced susceptibility to superantigen-associated streptococcal sepsis in human leukocyte antigen-DQ transgenic mice.
    Sriskandan S; Unnikrishnan M; Krausz T; Dewchand H; Van Noorden S; Cohen J; Altmann DM
    J Infect Dis; 2001 Jul; 184(2):166-73. PubMed ID: 11424013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF).
    Norrby-Teglund A; Newton D; Kotb M; Holm SE; Norgren M
    Infect Immun; 1994 Dec; 62(12):5227-33. PubMed ID: 7960098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bacterial superantigen streptococcal mitogenic exotoxin Z is the major immunoactive agent of Streptococcus pyogenes.
    Unnikrishnan M; Altmann DM; Proft T; Wahid F; Cohen J; Fraser JD; Sriskandan S
    J Immunol; 2002 Sep; 169(5):2561-9. PubMed ID: 12193726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic membrane-associated protein (CAP) isolated from Streptococcus pyogenes: as a new bacterial superantigen.
    Sato H; Itoh T; Rikiishi H; Kumagai K
    Microbiol Immunol; 1994; 38(2):139-47. PubMed ID: 8041301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of HLA-DR4 and human CD4 transgenes in mice determines the variable region beta-chain T-cell repertoire and mediates an HLA-DR-restricted immune response.
    Fugger L; Michie SA; Rulifson I; Lock CB; McDevitt GS
    Proc Natl Acad Sci U S A; 1994 Jun; 91(13):6151-5. PubMed ID: 8016129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of a new superantigen with potent mitogenic activity to murine T cells from Streptococcus pyogenes.
    Nemoto E; Rikiishi H; Sugawara S; Okamoto S; Tamura K; Maruyama Y; Kumagai K
    FEMS Immunol Med Microbiol; 1996 Sep; 15(2-3):81-91. PubMed ID: 8880132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo evidence for high frequency of I-Ab-reactive CD4+ T cells in HLA-DQ or HLA-DRA transgenic mice lacking endogenous MHC class I and/or class II expression.
    Ishimoto T; Yamamoto K; Fukui Y; Fukuda Y; Dohi K; Sasazuki T
    J Immunol; 1997 Oct; 159(8):3717-22. PubMed ID: 9378957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential presentation of group A streptococcal superantigens by HLA class II DQ and DR alleles.
    Norrby-Teglund A; Nepom GT; Kotb M
    Eur J Immunol; 2002 Sep; 32(9):2570-7. PubMed ID: 12207341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lethal shock induced by streptococcal pyrogenic exotoxin A in mice transgenic for human leukocyte antigen-DQ8 and human CD4 receptors: implications for development of vaccines and therapeutics.
    Welcher BC; Carra JH; DaSilva L; Hanson J; David CS; Aman MJ; Bavari S
    J Infect Dis; 2002 Aug; 186(4):501-10. PubMed ID: 12195377
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
    Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
    J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different role of human HLA-DR and -DQ molecules in xenogeneic transplantation using transgenic mice.
    Sireci G; Dieli F; Di Sano C; Salerno A
    Transplantation; 1999 Jul; 68(2):317-9. PubMed ID: 10440412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
    Simpson E; Takacs K; Altmann DM
    Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human CD4 and human major histocompatibility complex class II (DQ6) transgenic mice: supersensitivity to superantigen-induced septic shock.
    Yeung RS; Penninger JM; Kündig T; Khoo W; Ohashi PS; Kroemer G; Mak TW
    Eur J Immunol; 1996 May; 26(5):1074-82. PubMed ID: 8647170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.